Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-036074

Director sold 7,000 shares at an average $17.46 ($122,185)

  • Director acquired 8,289 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Henderson Jeffrey William · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Grant or award : show line 1 in the form 10b5-1 +8,289 41,866 D
2023-06-08 Sale : show line 2 in the form 10b5-1 −2,006 $16.87 $33,841 39,860 D
2023-06-08 Sale : show line 3 in the form 10b5-1 −4,994 $17.69 $88,344 34,866 D
Open-market sales · 7,000 sh · avg $17.46 · $122,185

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-07 Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) +12,666 12,666 D
Loading xslF345X04/doc4.xml…